Inactive Instrument

News Ventrus Biosciences Inc Nasdaq

Equities

US9228221019

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 28	Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 19	Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights	Mar. 28	AQ
Reverse Split: 1 of 12	Feb. 11	FA
Assembly Biosciences Announces Effective Date of Reverse Stock Split	Feb. 08	GL
Assembly Biosciences Announces Effective Date of Reverse Stock Split	Feb. 08	AQ
Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing	Jan. 19	MT
Assembly Biosciences, Inc. Provides Anticipated Development Milestones for 2024	Jan. 04	CI
Assembly Biosciences Provides Anticipated Development Milestones for 2024	Jan. 04	GL
Assembly Biosciences Provides Anticipated Development Milestones for 2024	Jan. 04	AQ
Assembly Biosciences, Inc. Appoints Tomas Cihlar to Serve on the Board	Dec. 07	CI
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Nov. 10	GL
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Nov. 10	AQ
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	Nov. 10	GL
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	Nov. 10	AQ
Assembly Biosciences: Q3 Earnings Snapshot	Nov. 08	AQ
Assembly Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates	Nov. 08	GL
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	Nov. 08	GL
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	Nov. 08	AQ
Assembly Biosciences, Inc. Appoints Anuj Gaggar as Chief Medical Officer	Nov. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ventrus Biosciences Inc Nasdaq

Equities

US9228221019

Summary

Filters